Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Is HLA type a possible cancer risk modifier in Lynch syndrome?

Lookup NU author(s): Dr Richard GallonORCiD, Dr Mauro Santibanez Koref, Dr Michael JacksonORCiD, Dr Gillian Borthwick

Downloads

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).

Publication metadata

Author(s): Ahadova A, Witt J, Haupt S, Gallon R, Hüneburg R, Nattermann J, Ten Broeke S, Bohaumilitzky L, Hernandez-Sanchez A, Santibanez-Koref M, Jackson MS, Ahtiainen M, Pylvänäinen K, Andini K, Grolmusz VK, Möslein G, Dominguez-Valentin M, Møller P, Fürst D, Sijmons R, Borthwick GM, Burn J, Mecklin JP, Heuveline V, von Knebel Doeberitz M, Seppälä T, Kloor M

Publication type: Review

Publication status: Published

Journal: International Journal of Cancer

Year: 2023

Volume: 152

Issue: 10

Pages: 2024-2031

Print publication date: 15/05/2023

Online publication date: 10/10/2022

Acceptance date: 16/09/2022

ISSN (print): 0020-7136

ISSN (electronic): 1097-0215

URL: https://doi.org/10.1002/ijc.34312

DOI: 10.1002/ijc.34312

Share